Tradestie Institutional Equity Comparison Engine

GNPX vs ABI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GNPX Overall Edge

GNPX Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genprex, Inc. Common Stock (GNPX) driven by superior Growth & Margin while ABI counters with relative strength in Momentum & Technical. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNPX N/M vs ABI N/M Fwd P/E
Growth & Margin Winner GNPX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner ABI
1Y -56.6% vs -1.6% ยท 52W Pos 11% vs 30%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
ABI US Equity
ABI
Institutional Equity
$24.59
+0.41% 1D
Market Cap N/A
1M Return +0.0%
1Y Return -1.58%
Forward P/E N/M
Unified AI Score
56.3 / 100 HOLD
Tech 75.0 Fund 63.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNPX -56.59% ABI -1.58% Spread: +55.17 pp (ABI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNPX TTM Op. Margin: 0.0% ABI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs ABI. Trailing 12-month operating profitability (GNPX 0.0% vs ABI N/A) and valuation multiples (GNPX N/M vs ABI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNPX (5) vs ABI (3)
Institutional Metric GNPX ABI Criterion Row Winner
Market Capitalization Scale $2.2M N/A Larger Scale GNPX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth GNPX
Operating Margin (TTM) Profitability 0.0% N/A Higher Margin GNPX
Net Profit Margin Profitability 0.0% N/A Higher Margin GNPX
Return on Equity (ROE) Capital Efficiency -233.7% N/A Higher ROE GNPX
52-Week Range Position Momentum 11% ($0โ€“$10) 30% ($24โ€“$25) Stronger Trend ABI
Beta / 30D Volatility Risk Regime -4.68ฮฒ ยท 96% Vol 0.01ฮฒ ยท 2% Vol Lower Realized Risk ABI
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 56.3 / 100 (HOLD) Higher Composite ABI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNPX vs ABI Buy Guide
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNPX nor ABI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.